EdgarLookup

Quince Therapeutics, Inc. — SC 13G/A Filings

20 SC 13G/A filings on record

This page lists all SC 13G/A filings submitted to the SEC by Quince Therapeutics, Inc. (QNCX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Quince Therapeutics, Inc. has filed 20 SC 13G/A documents with the SEC since 2016. To view all SEC filings by Quince Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-Q 144 3 3/A 4 4/A 424B3 424B4 424B5 5 8-A12B 8-K 8-K/A ARS CERT CORRESP D DEF 14A DEFA14A DRS EFFECT POS AM POS EX POSASR PRE 14A S-1 S-1/A S-3 S-3ASR S-8 SC 13D SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
SC 13G/A AMENDMENT NO. 2 0001214659-24-019112 Nov 14, 2024
SC 13G/A SC 13G/A 0001104659-24-086395 Aug 6, 2024
SC 13G/A AMENDMENT NO. 1 0001214659-24-002876 Feb 14, 2024
SC 13G/A 0001616824-24-000021 Feb 7, 2024
SC 13G/A QNCX_13G_A4 0001779453-23-000006 Feb 13, 2023
SC 13G/A SEC SCHEDULE 13G 0001422849-22-000154 Jul 8, 2022
SC 13G/A SEC SCHEDULE 13G 0001422849-22-000060 Feb 11, 2022
SC 13G/A SEC SCHEDULE 13G 0001422848-22-000169 Feb 11, 2022
SC 13G/A SEC SCHEDULE 13G 0001562230-21-000135 Dec 10, 2021
SC 13G/A SEC SCHEDULE 13G 0001562230-21-000137 Dec 10, 2021
SC 13G/A SEC SCHEDULE 13G 0001562230-21-000134 Oct 8, 2021
SC 13G/A SEC SCHEDULE 13G 0001562230-21-000132 Oct 8, 2021
SC 13G/A SC 13G/A 0001193125-21-133435 Apr 27, 2021
SC 13G/A SEC SCHEDULE 13G 0001422849-21-000132 Mar 10, 2021
SC 13G/A SEC SCHEDULE 13G 0001422848-21-000043 Feb 16, 2021
SC 13G/A CRTX13GA3 0001771620-21-000001 Feb 1, 2021
SC 13G/A SC 13G/A 0001422848-20-000029 Feb 14, 2020
SC 13G/A CORTEXYME, INC. SCH 13G 0001068238-20-000050 Feb 11, 2020
SC 13G/A SC 13G/A 0001771620-20-000001 Jan 7, 2020
SC 13G/A SC 13G/A 0001771620-19-000003 Jun 18, 2019